Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.03 | 3.14 | 0.11 |
Stocks | 96.97 | 96.97 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.52 | 21.31 |
Price to Book | 4.88 | 3.95 |
Price to Sales | 2.21 | 2.26 |
Price to Cash Flow | 16.92 | 16.43 |
Dividend Yield | 1.27 | 1.34 |
5 Years Earnings Growth | 11.39 | 10.95 |
Number of long holdings: 52
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.55 | 777.96 | -0.03% | |
UnitedHealth | US91324P1021 | 8.46 | 494.70 | +0.32% | |
Novo Nordisk B | DK0062498333 | 6.50 | 881.3 | -0.79% | |
Merck&Co | US58933Y1055 | 4.87 | 131.95 | +0.15% | |
Thermo Fisher Scientific | US8835561023 | 4.22 | 581.21 | +0.32% | |
AstraZeneca | GB0009895292 | 3.92 | 10,678.0 | -0.60% | |
Abbott Labs | US0028241000 | 3.43 | 113.66 | +0.16% | |
Roche Holding Participation | CH0012032048 | 3.16 | 229.70 | +1.30% | |
Sanofi | FR0000120578 | 2.93 | 90.96 | -0.87% | |
Becton Dickinson | US0758871091 | 2.51 | 247.45 | +0.37% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology a | 868.54M | 33.24 | 4.92 | 18.91 | ||
AXA Framlington Global Technology F | 155.48M | 33.24 | 4.91 | 18.90 | ||
GB00B5LXGG05 | 719.01M | 6.36 | 12.03 | 16.24 | ||
AXA Framlington UK Mid Cap Fund S I | 8.24M | 0.94 | 7.00 | 7.01 | ||
AXA Framlington UK Mid Cap Fund S A | 3.49M | 0.97 | 7.01 | 6.97 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review